Microcide Pharmaceuticals (MCDE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Microcide Pharmaceuticals (MCDE)

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Gary M. Reed who wrote ()	12/3/1996 1:20:00 AM
From: James Silverman	of 186

Gary, Ive been looking into Microcide and am getting fairly excited by what I see. I like the way they are combining combinatorial chemistry & genomics as well as using both natural and synthetic based chemicals in their screens. I also like their initial targets: antibiotic resistant bacterial strains. A very important and underserved target, yet lucrative ($23 billion current antibiotic market). I have exchanged a few e-mails with matt hogan (cfo or IR), he's been pretty helpful. I'm expecting an investment packet any day, so I can review the company further, prior to making an investment decision. I thought you may be able to illucidate further on what your thoughts are regarding the company. I'm particularly interested in among other things the structure of their joint ventures, what portion is MCDE paying and what kind of future royalties they will be receiving. Additionally what are they targeting in-house, sans partners. They seem to be relatively unnoticed, yet clearly have very strong propsects, albeit LT prospects. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext